BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19515021)

  • 41. Endothelial immunogenicity--a matter of matrix microarchitecture.
    Methe H; Hess S; Edelman ER
    Thromb Haemost; 2007 Aug; 98(2):278-82. PubMed ID: 17721607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human leukocyte antigen class II antibodies and transplant outcome.
    Duquesnoy RJ
    Transplantation; 2008 Sep; 86(5):638-40. PubMed ID: 18791442
    [No Abstract]   [Full Text] [Related]  

  • 43. Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR.
    Hirschberg H; Braathen LR; Thorsby E
    Immunol Rev; 1982; 66():57-77. PubMed ID: 6215331
    [No Abstract]   [Full Text] [Related]  

  • 44. Soluble HLA-G and control of angiogenesis.
    Le Bouteiller P; Fons P; Herault JP; Bono F; Chabot S; Cartwright JE; Bensussan A
    J Reprod Immunol; 2007 Dec; 76(1-2):17-22. PubMed ID: 17467060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.
    Stastny P; Zou Y; Fan Y; Qin Z; Lavingia B
    Contrib Nephrol; 2009; 162():99-106. PubMed ID: 19001817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expression.
    Das UN
    J Assoc Physicians India; 2007 Jul; 55 Suppl():56-65. PubMed ID: 17927013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microvasculature in gingivitis and chronic periodontitis: disruption of vascular networks with protracted inflammation.
    Zoellner H; Chapple CC; Hunter N
    Microsc Res Tech; 2002 Jan; 56(1):15-31. PubMed ID: 11810703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA class I antibody-mediated endothelial and smooth muscle cell activation.
    Zhang X; Valenzuela NM; Reed EF
    Curr Opin Organ Transplant; 2012 Aug; 17(4):446-51. PubMed ID: 22710387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding the immunoangiostatic CXC chemokine network.
    Balestrieri ML; Balestrieri A; Mancini FP; Napoli C
    Cardiovasc Res; 2008 May; 78(2):250-6. PubMed ID: 18252760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial cells as targets of allograft rejection.
    Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C
    Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation.
    Dragun D; Hegner B
    Contrib Nephrol; 2009; 162():129-39. PubMed ID: 19001820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspects of adaptive host response in periodontitis.
    Berglundh T; Donati M
    J Clin Periodontol; 2005; 32 Suppl 6():87-107. PubMed ID: 16128832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stress-mediated hormetic modulation of aging, wound healing, and angiogenesis in human cells.
    Rattan SI; Sejersen H; Fernandes RA; Luo W
    Ann N Y Acad Sci; 2007 Nov; 1119():112-21. PubMed ID: 18056960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications.
    Praprotnik S; Blank M; Meroni PL; Rozman B; Eldor A; Shoenfeld Y
    Arthritis Rheum; 2001 Jul; 44(7):1484-94. PubMed ID: 11465698
    [No Abstract]   [Full Text] [Related]  

  • 55. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
    MuixĂ­ L; Alvarez I; Jaraquemada D
    Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble mediators of inflammation during tumor development.
    Robinson SC; Coussens LM
    Adv Cancer Res; 2005; 93():159-87. PubMed ID: 15797447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Circulating endothelial microparticles: a new marker of vascular injury].
    Boulanger CM; Leroyer AS; Amabile N; Tedgui A
    Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-16 network in inflammation and allergy.
    Conti P; Kempuraj D; Kandere K; Di Gioacchino M; Reale M; Barbacane RC; Castellani ML; Mortari U; Boucher W; Letourneau R; Theoharides TC
    Allergy Asthma Proc; 2002; 23(2):103-8. PubMed ID: 12001788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenetics of ageing.
    Naumova E; Ivanova M; Pawelec G
    Int J Immunogenet; 2011 Oct; 38(5):373-81. PubMed ID: 21726414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chemokine RANTES activity and its potential role as a target for diagnosis and therapy].
    Basiewicz-Worsztynowicz BM; Karnas-Kalemba WZ
    Wiad Lek; 2004; 57(11-12):653-8. PubMed ID: 15865244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.